Relaunching the NBA, repairing medical devices, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

This week, we’re highlighting some of the most interesting perspectives and opinions about the fight against COVID-19.

Here are our must reads for this week.

1. U.S. Gives up to $1.2 Billion to AstraZeneca for COVID-19 Vaccine

The day before kicking off a combined Phase 2/3 coronavirus vaccine trial with Oxford University, biopharmaceutical company AstraZeneca landed a $1.2 billion contract with the U.S. government. The terms? Deliver at least 300 million doses of a coronavirus vaccine to the U.S. by October.

2. Introducing the World’s Largest Medical Repair Database, Free for Everyone

In response to the coronavirus pandemic, iFixIt — an online database of user manuals and repair instructions for various gadgets and electronic gear — pivoted its attention to medical equipment. This week, it made the massive library of documentation available to anyone who needs it.

3. ‘How Could the CDC Make That Mistake?’

The CDC has stumbled more than once while responding to the coronavirus pandemic. Now, The Atlantic has discovered that the agency has been combining figures for two very different types of COVID-19 tests — one designed to track active infections and the other past cases — leaving health experts baffled.

4. The Testing Plans at the Center of the NBA’s Relaunch Efforts

The National Basketball Association’s season was cut short by the coronavirus pandemic. This piece by The Ringer takes a look at the league’s ideas for getting the season going again, which include holding all games in one location and a whole lot of testing.

5. The World May Be Overestimating the Power of COVID-19 Vaccines

The development of an effective coronavirus vaccine has taken center stage in the battle against COVID-19, with seemingly expert after expert emphasizing the importance of inoculation. This STAT article aims to temper expectations on just how big a role a vaccine could play in bringing the pandemic to an end.

Did we leave something off this list? We want to hear about what you’re reading and any interesting ideas you’d like us to cover. Drop us a line at [email protected].

Nasal COVID-19 vaccine outperforms mRNA shots in new study
A live attenuated vaccine for COVID-19 that delivered via a nasal spray outperformed several shots in a preclinical study.
Viruses cause 200+ diseases. This one drug may be able to treat them all.
New Zealand-based startup Kimer Med wants to create an antiviral that would be effective against many known viruses — and unknown.
Inhaling this powder shields lungs from infection
An inhalable powder that acts as an “invisible mask” for the lungs could potentially help end the COVID-19 pandemic.
Yale researchers have found a way to spot new viruses
By screening negative nasal swabs for a specific antiviral protein, a Yale team believes we may be able to find hidden viruses before they emerge.
First-of-its-kind nasal vaccine for COVID-19 deployed in India
India has begun deploying a nasal vaccine for COVID-19 that may be able to prevent infections, not just limit their severity.
Up Next
Subscribe to Freethink for more great stories